Sign in

CIK 0001703647

  • Non-accelerated filer
  • Smaller reporting company

Korro Bio, Inc.

Sign in to watch
Ticker
KRRO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
472324450
Phone
+1 617-468-1999
Business address
60 FIRST STREET, 2ND FLOOR, SUITE 250, CAMBRIDGE, MA, 02141
Former names
Frequency Therapeutics, Inc.
  1. 3 Insider Initial Statement of Ownership
  2. 3 Insider Initial Statement of Ownership
  3. 3 Insider Initial Statement of Ownership
  4. 4 Planned sale VP Finance & Operations sold 464 shares at an average $0.58 ($269)
  5. 4 Planned sale President and CEO sold 5,922 shares at an average $0.55 ($3,248)
  6. 4 Planned sale VP Finance & Operations sold 464 shares at an average $0.65 ($299)
  7. 4 Planned sale President and CEO sold 5,628 shares at an average $0.64 ($3,604)
  8. 4 Planned sale VP Finance & Operations sold 466 shares at an average $0.64 ($301)
  9. 4 Planned sale President and CEO sold 5,510 shares at an average $0.65 ($3,576)
  10. 4 Planned sale President and CEO sold 5,523 shares at an average $0.68 ($3,728)
  11. 4 Planned sale VP Finance & Operations sold 487 shares at $0.64 ($312)
  12. 4 Planned sale President and CEO sold 5,608 shares at an average $0.68 ($3,814)
  13. 4 Planned sale VP Finance & Operations sold 479 shares at an average $0.67 ($319)
  14. 4 Planned sale President and CEO sold 5,407 shares at an average $0.68 ($3,702)
  15. 4 Planned sale VP Finance & Operations sold 455 shares at an average $0.68 ($310)
  16. 4 Planned sale President and CEO sold 5,266 shares at an average $0.56 ($2,926)
  17. 4 Planned sale VP Finance & Operations sold 463 shares at an average $0.53 ($243)
  18. 4 Planned sale President and CEO sold 5,475 shares at an average $0.49 ($2,710)
  19. 4 Planned sale VP Finance & Operations sold 460 shares at an average $0.49 ($225)
  20. 4 Planned sale VP Finance & Operations sold 450 shares at an average $0.50 ($225)

Page 7 of 18 · 354 filings